Simplex Trading
NMRA icon

Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History

Simplex Trading’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
59,700
+34,500
+137% +$89.4K ﹤0.01% 4909
2025
Q4 		$45.1K Sell
25,200
-16,600
-40% -$36.3K ﹤0.01% 5742
2025
Q3 		$76K Buy
41,800
+4,000
+11% +$6.47K ﹤0.01% 6044
2025
Q2 		$27K Sell
37,800
-17,800
-32% -$13.5K ﹤0.01% 6498
2025
Q1 		$55K Sell
55,600
-90,500
-62% -$155K ﹤0.01% 5668
2024
Q4 		$1.55M Buy
146,100
+63,700
+77% +$763K ﹤0.01% 2419
2024
Q3 		$1.09M Buy
82,400
+82,000
+20,500% +$957K ﹤0.01% 2856
2024
Q2 		$3K Sell
400
-600
-60% -$6.21K ﹤0.01% 8136
2024
Q1 		$13K Sell
1,000
-500
-33% -$8.08K ﹤0.01% 7424
2023
Q4 		$25K Buy
+1,500
New +$18.4K ﹤0.01% 6740

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Simplex Trading's NMRA Position: Q1 2026 in Review

Simplex Trading opened a new position in Neumora Therapeutics (NMRA) in Q1 2026: 129,156 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #4021 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NMRA as recently as Q3 2025.

Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 6 quarters since. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Simplex Trading held 129,156 shares of Neumora Therapeutics worth $252K as of Q1 2026.
  • Neumora Therapeutics was a new Simplex Trading position in Q1 2026.
  • Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4021 holding.
  • Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.